A variety of molecular tools including polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP), isoenzymes analysis and sequence analysis of several genes have provided genotypic information about *Giardia duodenalis* ([@B18], [@B07], [@B25], [@B09], [@B17]). Based on these analyses, isolates of *G. duodenalis* have been classified into seven genetic assemblages, A-G ([@B23], [@B18]). Assemblages A and B, infect humans as well as a number of other hosts, whereas the other genetic assemblages C-G are restricted to domestic animals, livestock and wild animals ([@B04] ). Assemblage A, in humans has been classified into two groups, I and II and assemblage B has been classified into groups, III and IV ([@B23]). PCR-RFLP has been used previously to target the glutamate dehydrogenase ( *gdh* ) *locus* . This gene has been shown to be a reliable, easy and cost-effective method to identify *G. duodenalis* isolates directly from faeces ([@B23], [@B07], [@B08], [@B25], [@B17]). Stud-ies on the relationship between parasite genotype and symptoms have been mixed, though a genotypic analysis using PCR-RFLP amplification of the *gdh* gene did find a strong genetic link with clinical symptomatology in 18 Dutch patients ([@B12]).

*G. duodenalis* is a common parasite in Ecuadorian children living in rural communities, with prevalence measures of approximately 20% ([@B20], [@B13]). This is in agreement with five years of case control data collected from the communities included in this study ([@B05]).

We report here for the first time the genotypes of *G. duodenalis* present in humans in rural communities in the northern coastal rainforests of Ecuador.

The study was conducted in North-western Ecuador within the province of Esmeraldas and the canton Eloy Alfaro. The study region comprises approximately 150 villages located along the three rivers, Cayapas, Santiago and Onzole. Between November 2004-July 2005, 595 stool samples were collected from 152 cases (diarrhoea) and 443 controls and frozen in liquid nitrogen before being transported to the lab in Quito. In Quito, the presence of *Giardia* antigen was tested using an ELISA kit (RIDASCREEN *Giardia*, R-Biopharm, USA).

DNA extraction was performed on the 154 faecal samples that were positive for infection by ELISA and samples were stored at -20°C until required for PCR and RFLP analysis. DNA extraction, PCR \[using primers GDHeF, GDHiF and GDHiR to identify a fragment of approximately 432 base pairs (bp) of the *gdh* \] and RFLP was exactly as described by [@B18] and [@B07] with the following changes: the concentration of the forward primers in the PCR reaction were changed to 25 pmol to improve sensitivity; RFLP digestion was increased to four units for 8 h at 37°C to improve cleavage by the restriction enzymes NlaIV and RsaI. PCR amplification of samples included a known *Giardia* positive (courtesy of Baca Ortiz Hospital, Quito) and a negative control (PCR water instead of DNA). *Giardia* RFLP assemblages were identified using a diagnostic genotyping profile as shown previously by [@B18] and [@B03]. One positive control identified as assemblage AII and another as assemblage BIII were used as references for the RFLP.

The estimated weighted prevalence of *Giardia* infection in our study population was 24%. All but three stool samples were analysed for *Giardia* using ELISA. Of the 592 samples analysed, 154 (26%) were positive for *Giardia* ([Table I](#t01){ref-type="table"} ). Subsequently, all ELISA-positive samples were analysed by semi-nested PCR and 74 (48%) exhibited a band at 432 bp specific for the *gdh* gene ([Fig. 1](#f01){ref-type="fig"}). Of these 74 samples, 69 were genotyped using RFLP ([Table II](#t02){ref-type="table"}), with the NlaIV restriction enzyme used to distinguish between assemblage A and assemblage B genotypes ( [Fig. 2A](#f02){ref-type="fig"}). Those identified as assemblage B were further processed using the RsaI restriction enzyme ([Fig. 2B](#f02){ref-type="fig"}). Five (7%) samples that were PCR-positive could not be genotyped because the bands could not be clearly identified. These samples were excluded from our analysis.

TABLE IA summary of ELISA test results in case and control stool samplesInfection status*Giardia* -negative (n)*Giardia* -positive (n)Not tested (n)Total (n)Diarrhoea85661152No diarrhoea353882443Total4381543595

TABLE IISummary of expected band sizes from *Giardia duodenalis* glutamate dehydrogenase polymerase chain reaction-restriction fragment length polymorphismAssemblageand groupRestrictionenzymeDiagnostic band size(base pairs)AIN1aIV90, 120, 150AIIN1aIV70, 80, 90, 120BIIIRsaI130, 300BIVRsaI430AII, BIIINlaIV and RsaI90, 120, 290, 130, 300

Fig. 1amplification of the 432 base pairs (bp) band specific for the glutamate dehydrogenase gene of *Giardia duodenalis.* Lane 1: molecular weight marker 1,000 bp; 2: *Giardia* positive control 432 bp; 3: *Giardia* positive 432 bp.

Fig. 2ethidium bromide stained 2% high-resolution agarose gel showing DNA amplified at the glutamate dehydrogenase for genetic assemblages AII and B digested with Nla IV (A) and genetic assemblages BIII and BIV digested with RsaI (B). Lane 1: molecular weight marker 1,000 base pairs (bp); 2, 5, 6: assemblage B (120 bp, 290 bp); 3, 4: assemblage AII (70 bp, 80 bp, 90 bp, 120 bp); 7: molecular weight marker 1,000 bp; 8, 9: assemblage BIII (130 bp, 300 bp); 10, 11: assemblage BIV (430 bp).

In our study, all four genotypes were identified and the presence/absence of diarrhoea examined ([Table III](#t03){ref-type="table"}). Assemblage B was seen to be predominant (42 of 69 or 61%) with group BIII the most common of the four genotypes (26 or 38%). This is in agreement with previous studies ([@B02], [@B04], [@B14], [@B15], [@B01], [@B16]). Assemblage A was found in 22 of the 69 isolates (32%) with group II (19 of 69 or 28%) the most common. Assemblage BIV was found in 16 (23%) and only three individuals were infected with Group AI (4%); this low frequency is consistent with the literature ([@B02], [@B04], [@B03]). Interestingly, five individuals (7%) in this study were co-infected with both genotypes AII and BIII, which also has been previously documented ([@B02], [@B03], [@B16]). Overall, the odds ratio (OR) of diarrhoea in individuals infected with *Giardia,* compared to those uninfected, was 3.11 (95% CI = 2.11, 5.10). The OR of diarrhoea associated with assemblages B and A, each compared to no infection with *Giardia,* were 2.94 \[95% confidence interval (CI) = 1.45, 5.81\] and 3.46 (95% CI = 1.83, 9.24), respectively. The associations between diarrhoea and specific genotypes within assemblage A and B were similar to those reported above ([Table IV](#t04){ref-type="table"}).

TABLE IIIFrequency of symptomatic individuals (diarrhoea) across *Giardia duodenalis* genotypesInfection statusAI (n)AII (n)BIII (n)BIV (n)Not determined (n)Mix (n)*Giardia* -negative (n)Diarrhoea191073285No diarrhoea21015923353Unknown0010000Total319261655438

TABLE IVOdds ratios (OR) of diarrhoea associated with infection status and bootstrapped 95% confidence intervals (CI)Infection statusOR95% CI*Giardia* infection (ELISA-positive)3.112.11, 5.10Assemblage A3.461.83, 9.24Assemblage A, group INANAAssemblage A, group II3.741.93, 11.74Assemblage B2.941.45, 5.81Assemblage B, group III2.771.28, 6.34Assemblage B, group IV3.230.98, 10.66[^1]

Some prior studies have suggested that assemblage A infections are more likely to cause diarrhoea than assemblage B ([@B19], [@B11], [@B07], [@B21]); we, however, found no evidence of differential pathogenicity between assemblage A and B, which was in agreement with findings by [@B10] and Ceu Souza and Poiares da Silva (2004).

Of the 154 ELISA-positive samples analysed for the presence of the *gdh* gene, only 74 (48%) were positive, likely due to low numbers of cysts in the faeces of some of our samples. This lack of PCR sensitivity for the *gdh* gene has been noted by other groups, such as [@B02], [@B07] and [@B25], who also suggested that absence of this band was due to insufficient densities of cysts within the sample. Nested PCR analysis requires a high cyst density and *Giardia* cysts are susceptible to degradation ([@B02]). To avoid decreases in cyst density, samples should be frozen soon after collection to prevent degradation by proteases etc. Freeze-thawing of the samples may also be a reason for degradation, suggesting that ELISA and DNA extraction should be performed on fresh samples.

Recent studies ([@B24], [@B22]) have shown the presence of human genotypes, such as AI and AII, in livestock and pets. Future research on *Giardia* infection within animal populations in close proximity to humans could address whether or not those *Giardia* genotypes found in humans are being transmitted zoonotically.
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[^1]: NA: not available.
